At a glance
ClinicalIndex Comparison RecordN/ACompleted· 196 enrolled
Drug / intervention
HIV Anti-retroviral Background Therapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Visceral Adiposity Measurement and Observation Study
In Brief
An observational study evaluating Diagnostic Test and HIV Anti-retroviral Background Therapy for HIV and 18 related conditions. Completed, enrolled 196 participants across 8 sites.
Detailed Summary
The Visceral Adiposity Measurement and Observation Study
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV, HIV-Infections, HIV-1-infection, HIV I Infection, HIV Lipodystrophy, HIV Infection Primary, HIV-Associated Lipodystrophy, HIV Disease Progression, Lipohypertrophy, Liver Diseases, NAFLD, NASH, Liver Fibrosis, Hepatic Fibrosis, Waist Circumference, BMI, Ectopic Fat, Liver Fat, Hepatic Steatosis
CountriesUnited States
CollaboratorsDacima Consulting, Medpace, Inc., Vanderbilt University Medical Center, Echosens
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartApr 2022
First PostedMay 2022
Primary CompletionOct 2023
TodayJul 2026
First PostedMay 20, 2022
Enrollment StartApr 18, 2022
Primary CompletionOct 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.1 years ago
Interventions
Diagnostic Testother
Standard diagnostic tests.
HIV Anti-retroviral Background Therapydrug
All participants are required be on continuous HIV Anti-retroviral Background Therapy. No intervention on drug is part of the Study.